These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 38195304)
1. Immunologic Effects of Heparin Associated With Hemodialysis: Focus on Heparin-Induced Thrombocytopenia. Warkentin TE Semin Nephrol; 2023 Nov; 43(6):151479. PubMed ID: 38195304 [TBL] [Abstract][Full Text] [Related]
2. When heparin causes thrombosis: significance, recognition, and management of heparin-induced thrombocytopenia in dialysis patients. Chang JJ; Parikh CR Semin Dial; 2006; 19(4):297-304. PubMed ID: 16893407 [TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of acute systemic reaction and detection of IgG antibodies against PF4/heparin complexes in hemodialysis patients. Matsuo T; Wanaka K; Miyasita K; Prechel M; Walenga JM Thromb Res; 2012 Apr; 129(4):474-8. PubMed ID: 22088491 [TBL] [Abstract][Full Text] [Related]
4. Heparin-induced thrombocytopenia. Warkentin TE Hematol Oncol Clin North Am; 2007 Aug; 21(4):589-607, v. PubMed ID: 17666280 [TBL] [Abstract][Full Text] [Related]
5. Platelet count recovery and seroreversion in immune HIT despite continuation of heparin: further observations and literature review. Shih AW; Sheppard JI; Warkentin TE Thromb Haemost; 2017 Oct; 117(10):1868-1874. PubMed ID: 28837208 [TBL] [Abstract][Full Text] [Related]
7. Role of platelet factor 4-heparin complex antibody (HIT antibody) in the pathogenesis of thrombotic episodes in patients on hemodialysis. Nakamoto H; Shimada Y; Kanno T; Wanaka K; Matsuo T; Suzuki H Hemodial Int; 2005 Oct; 9 Suppl 1():S2-7. PubMed ID: 16223438 [TBL] [Abstract][Full Text] [Related]
8. The identification and management of heparin-induced thrombocytopenia in the vascular patient. LaMuraglia GM; Houbballah R; Laposata M J Vasc Surg; 2012 Feb; 55(2):562-70. PubMed ID: 22188737 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of circuit and AV fistula clotting and detection of anti-PF4/heparin complex antibodies in hemodialysis patients suspected of having heparin-induced thrombocytopenia. Matsuo T; Wanaka K; Walenga JM Clin Appl Thromb Hemost; 2013; 19(1):73-8. PubMed ID: 22345486 [TBL] [Abstract][Full Text] [Related]
11. Heparin-induced thrombocytopenia, a prothrombotic disease. Levy JH; Hursting MJ Hematol Oncol Clin North Am; 2007 Feb; 21(1):65-88. PubMed ID: 17258119 [TBL] [Abstract][Full Text] [Related]
12. Prothrombotic factors enhance heparin-induced thrombocytopenia and thrombosis in vivo in a mouse model. Reilly MP; Taylor SM; Franklin C; Sachais BS; Cines DB; Williams KJ; McKenzie SE J Thromb Haemost; 2006 Dec; 4(12):2687-94. PubMed ID: 16961586 [TBL] [Abstract][Full Text] [Related]
13. Heparin-induced thrombocytopenia: diagnosis and management. Liebman HA Vascular; 2008; 16 Suppl 1():S71-6. PubMed ID: 18544310 [TBL] [Abstract][Full Text] [Related]
15. [Patient who developed heparin-induced thrombocytopenia type II after 24 years on hemodialysis]. Gavranić BB; Basić-Jukić N; Kes P Acta Med Croatica; 2012 Oct; 66 Suppl 2():68-71. PubMed ID: 23513420 [TBL] [Abstract][Full Text] [Related]
16. Anti-PF4/heparin antibodies are associated with arteriovenous fistula thrombosis in non-diabetic hemodialysis patients. Tsai YF; Chen CA; Kuo C; Lin KC Clin Exp Nephrol; 2012 Apr; 16(2):300-5. PubMed ID: 22038266 [TBL] [Abstract][Full Text] [Related]
17. Risk factors for thrombosis in patients with immune mediated heparin-induced thrombocytopenia. Fabris F; Luzzatto G; Soini B; Ramon R; Scandellari R; Randi ML; Girolami A J Intern Med; 2002 Aug; 252(2):149-54. PubMed ID: 12190890 [TBL] [Abstract][Full Text] [Related]
18. Heparin-induced thrombocytopenia: a ten-year retrospective. Warkentin TE Annu Rev Med; 1999; 50():129-47. PubMed ID: 10073268 [TBL] [Abstract][Full Text] [Related]